Comparison of the Influence of tDCS and tACS Treatment on Pain Perception and Severity of Symptoms in Patients with Migraine

Comparison of the Influence of tDCS and tACS Noninvasive Brain Stimulation Treatments on Pain Perception and Severity of Symptoms in Patients with Migraine

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221230056984N1

Enrollment

Registered

2023-06-08

Start date

2023-06-20

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention group No.1: A Group that receives the tDCS protocol and comprises 15 people identified by A code. Anodal tDCS will be applied on their left lobe primary motor cortex (M1)

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Suffering from migraine based on the diagnosis of one of internal neurologists, neurologists and pain specialists

Exclusion criteria

Exclusion criteria: Having a history of hospitalization in a psychiatric hospital Suffering from severe depression or anxiety Having a history of cardiovascular diseases (such as high blood pressure) Addiction to alcohol or other substances Suffering from other forms of headache, including tension headaches, sinusitis, and headaches caused by drug abuse Suffering from neurological disorders such as epilepsy, stroke, head and neck trauma, and cerebrovascular diseases Starting the use of medication (in case of first visit) or changing the prescribed medication, from two weeks before the intervention to two weeks after the end of the intervention. Previous history of receiving any other brain stimulation Not having at least primary education

Design outcomes

Primary

Measure	Time frame
Pain Perception Score. Timepoint: Before starting and after the ending of intervention. Method of measurement: McGill Pain Perception Questionnaire (MPQ).;Severity of migraine symptoms. Timepoint: Before starting and after the ending of intervention. Method of measurement: Ahvaz Migraine Questionnaire (AMQ).;Migraine duration. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.;Severity of migraine attack. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.;Number of migraine attacks. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.	—

Measure

Time frame

Pain Perception Score. Timepoint: Before starting and after the ending of intervention. Method of measurement: McGill Pain Perception Questionnaire (MPQ).;Severity of migraine symptoms. Timepoint: Before starting and after the ending of intervention. Method of measurement: Ahvaz Migraine Questionnaire (AMQ).;Migraine duration. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.;Severity of migraine attack. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.;Number of migraine attacks. Timepoint: Before starting and after the ending of intervention. Method of measurement: MIDAS Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Rigi Kote

Zahedan University of Medical Sciences

brkpsycho1988@gmail.com+98 54 3351 3778

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026